美罗培南
粘菌素
环丙沙星
微生物学
生物膜
鲍曼不动杆菌
铜绿假单胞菌
肺炎克雷伯菌
抗生素
呼吸机相关性肺炎
最小抑制浓度
不动杆菌
肺炎
肺炎克雷伯菌
生物
医学
抗生素耐药性
细菌
内科学
大肠杆菌
遗传学
基因
生物化学
作者
Betül Çopur,Sibel Döşler,Zerrin Aktaş,Seniha Başaran,Serap Şimşek-Yavuz,Atahan Çağatay,Oral Öncül,Halit Özsüt,Haluk Eraksoy
出处
期刊:Future Microbiology
[Future Medicine]
日期:2022-09-01
卷期号:17 (13): 1027-1042
被引量:3
标识
DOI:10.2217/fmb-2021-0305
摘要
Background: The authors aimed to determine the efficacy of frequently used antibiotics, alone or in combination, against biofilms of ventilator-associated pneumonia isolates. Materials & methods: The authors determined the MICs, minimum biofilm inhibitory concentrations and minimum biofilm eradication concentrations of meropenem, ciprofloxacin and colistin as well as their combinations against planktonic forms and biofilms of Pseudomonas aeruginosa, Klebsiella pneumoniae and Acinetobacter baumannii clinical isolates. Results: Generally, the minimum biofilm inhibitory concentrations and minimum biofilm eradication concentrations of the antibiotics were 1000-fold higher than their MICs, and synergy was provided by different concentrations of meropenem-colistin and meropenem-ciprofloxacin combinations with checkerboard and time–kill curve methods. Conclusion: The combination of meropenem and ciprofloxacin seems to be a good candidate for the treatment of biofilm-associated infections; none of the concentrations obtained as a result of the synergy test were clinically significant.
科研通智能强力驱动
Strongly Powered by AbleSci AI